Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis
- PMID: 50402
- DOI: 10.1099/00221287-88-2-269
Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis
Abstract
Phenotypes of isolates of Mycobacterium tuberculosis H37RV showing resistance to the aminoglucoside antibiotics streptomycin, viomycin, kanamycin, capreomycin, tuberactinomycin N, lividomycin and paromomycin could be grouped into the following types: (I) resistant only to different levels of streptomycins; (2) resistant only to a low level of kanamycin; (3) triply resistant, to low levels of viomycin, tuberactinomycin N and capreomycin; (4) triply resistant, to a low level of kanamycin and high levels of lividomycin and paromomycin; (5) quadruply resistant, to a low level of capreomycin and high levels of kanamycin, lividomycin and paromomycin; (6) hextuply resistant, to high levels of viomycin, tuberactinomycin N, capreomycin, kanamycin, lividomycin, and paromomycin. Three modificatied types of the latter were also observed. Appearance rates of the six types were estimated as 10(-6) to 10(-9), 10(-6), 10(-6) to 10(-7), 10(-8), 10(-8), and 10(-8) to 10(-9), respectively, in a total viable population of the parent strain. Mutations to all phenotypes were considered to be produced by single mutations. According to cross-resistance relationships, aminoglucoside antibiotics were classified into three groups: (I) streptomycin; (II) viomycin, tuberactinomycin N and capreomycin; (III) kanamycin, lividomycin and paromomycin. No cross-resistance relationship between streptomycin and other antibiotics was observed. Resistances to viomycin, tuberactinomycin N and capreomycin occurred by single mutation to type 3. Resistances to kanamycin, lividomycin and paromomycin occurred by single mutations to types 4 and 5. Low resistance to capreomycin was produced by mutation to type 5. Therefore capreomycin was considered to be an intermediate between the second and third groups. These two groups had a close relationship, as resistance to all six agents in these groups could be produced by a single mutation to type 6 (and its modified types).
Similar articles
-
[Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].Kekkaku. 1975 May;50(4-5):123-30. Kekkaku. 1975. PMID: 49449 Japanese. No abstract available.
-
Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.J Antibiot (Tokyo). 1976 Oct;29(10):1124-6. doi: 10.7164/antibiotics.29.1124. J Antibiot (Tokyo). 1976. PMID: 62857 No abstract available.
-
[Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].Kekkaku. 1977 Apr;52(4):171-5. Kekkaku. 1977. PMID: 69737 Review. Japanese. No abstract available.
-
[Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].Kekkaku. 1976 Dec;51(12):477-87. Kekkaku. 1976. PMID: 65494 Japanese. No abstract available.
-
Tuberactinomycin antibiotics: Biosynthesis, anti-mycobacterial action, and mechanisms of resistance.Front Microbiol. 2022 Aug 11;13:961921. doi: 10.3389/fmicb.2022.961921. eCollection 2022. Front Microbiol. 2022. PMID: 36033858 Free PMC article. Review.
Cited by
-
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2005 Feb;49(2):571-7. doi: 10.1128/AAC.49.2.571-577.2005. Antimicrob Agents Chemother. 2005. PMID: 15673735 Free PMC article.
-
Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 1998 May;42(5):1295-7. doi: 10.1128/AAC.42.5.1295. Antimicrob Agents Chemother. 1998. PMID: 9593173 Free PMC article.
-
Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2005 Aug;49(8):3192-7. doi: 10.1128/AAC.49.8.3192-3197.2005. Antimicrob Agents Chemother. 2005. PMID: 16048924 Free PMC article.
-
Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2015 Sep;59(9):5427-34. doi: 10.1128/AAC.00662-15. Epub 2015 Jun 22. Antimicrob Agents Chemother. 2015. PMID: 26100699 Free PMC article.
-
Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2003 Sep;47(9):2971-3. doi: 10.1128/AAC.47.9.2971-2973.2003. Antimicrob Agents Chemother. 2003. PMID: 12937004 Free PMC article.